Mylan NV Executive Chairman Robert Coury was named chairman
of the generic drugmaker's board in a move that reduces his role in management of the company and could give Heather Bresch greater responsibilities as chief executive.
Not exact matches
Generic drugmaker Mylan has proposed buying Perrigo for about $ 29 billion in cash and stock in what would be the biggest pharmaceutical deal
of the year so far.
German health - care group Fresenius said it had decided to pull out
of its planned acquisition
of Akorn after it found data integrity breaches at the U.S.
generic drugmaker.
Akorn shares plummeted Monday after Germany's Fresenius Medical ditched its planned $ 5 billion takeover amid allegations
of data misconduct at the Lake Forest, Ill. - based
generic drugmaker.
We cover biopharma companies end - to - end — whether they're small, specialty
drugmakers,
generics companies or the biggest
of Big Pharma — highlighting the accomplishments and acknowledging the defeats that all
of them experience in the complicated, competitive pharmaceuticals industry.
Akorn — German
drugmaker Fresenius pulled out its $ 4.75 billion deal to buy the U.S.
generic drugmaker, saying it had found «material breaches»
of Food and Drug Administration data integrity requirements at Akorn.
The
drugmaker's bonds were cut to junk from investment grade by Moody's after its US$ 41 - billion buyout
of Allergan Plc's
generics business in 2016 left the company with a debt load that outweighed its value in the stock market.
In an effort to extend the protection, Sanofi obtained a series
of patents for other indications, which were challenged by Apotex, a
generic drugmaker.
Indian
generic drugmakers currently produce nearly 40 percent
of generic drugs and over-the-counter products and 10 percent
of finished dosages used in the United States.